Results 31 to 40 of about 1,262,540 (239)
Introduction and purpose: Drug-induced reaction with eosinophilia and systemic symptoms (DRESS) is a severe, life-threatening systemic drug reaction.
Aleksandra Hajduk +7 more
doaj +1 more source
A Rare Presentation of Clozapine-Induced DRESS Syndrome
Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome) is an uncommon side effect of certain medications. It causes a skin reaction, with eosinophilia and other organ involvement. This case describes a presentation of a 32-year-old female
Carmel Moazez +3 more
doaj +1 more source
SÍNDROME POR REACCIÓN A DROGAS CON EOSINOFILIA Y SÍNTOMAS SISTÉMICOS (DRESS)
El síndrome DRESS (por sus siglas en inglés de drug rash with eosinophilia and systemic symptoms) es una reacción grave de hipersensibilidad a diferentes fármacos, entre los que podemos mencionar los anticonvulsivos, sulfonamidas y algunos fármacos ...
Hugo Milione +3 more
doaj +2 more sources
LAMOTRIGINE INDUCED DRESS SYNDROME [PDF]
Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, is a type of hypersensitivity reaction, mainly due to anti-epileptic drugs. Lamotrigine is a newer broad spectrum antiepileptic that can be used in both children and adults.
O, Balaji +4 more
core +3 more sources
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a drug reaction commonly related to eosinophilia, from uncertain epidemiology, and without consensus for diagnosis and treatment globally.
José Dario Martínez +8 more
doaj +1 more source
Schematic illustration of the proposed mechanism: PEG/RGD‐PSLs mimic apoptotic cells to engage PS receptors (notably CD300a), transducing an inhibitory signal that suppresses the MyD88/NF‐κB pathway, leading to global anti‐inflammatory and pro‐reparative effects.
Lele Wu +10 more
wiley +1 more source
An immunomodulatory hydrogel (iGEL) forms spontaneously upon subcutaneous injection, acting as a tissue‐adhesive depot. It releases anti‐rejection and regenerative agents in response to inflammation, suppressing T‐cell activity, promoting vascular repair, and restoring allograft function without systemic immunosuppression.
Ning Wang +14 more
wiley +1 more source
DRESS syndrome in a patient undergoing stem cell transplantation: Can sirolimus be involved?
We present a case of sirolimus‐induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a stem cell transplant patient. Sirolimus is an immunosuppressive drug that inhibits the mammalian target of rapamycin (mTOR) pathway.
Fortunato Cassalia +4 more
doaj +1 more source
Introduction Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome refers to a cluster of clinical symptoms/signs related to drug hypersensitivity. The main clinical features include fever, skin rash, eosinophilia, enlarged lymph nodes,
R. De Filippis +3 more
doaj +1 more source
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang +6 more
wiley +1 more source

